Activity Details
| Credit Types: |
AMA PRA Category 1 (CME) ACPE (CPE) |
| Credit/Hours: |
2.00 (CME) 2.40 (CPE) |
| Cost: | $9.95 |
| Released: | Oct 29, 2007 |
| Expires: | Oct 31, 2009 |
| System Requirements: |
|
| Activity Rating: | 4 / 5 Stars 7 Total Ratings |
| Rate This Activity: |
Faculty
David J. Feola, PharmD, PhD, BCPSAssistant Professor of Pharmacy
University of Kentucky College of Pharmacy
Frank Romanelli, PharmD, MPH, BCPSAssistant Dean for Education / Associate Professor of Pharmacy
University of Kentucky College of Pharmacy
Clinical Specialist in HIV/AIDS
University of Kentucky Medical Center
Needs Statement
Social and clinical advances in the management of human immunodeficiency virus (HIV) infection and the acquired immune deficiency syndrome (AIDS) continue to occur across the globe. Significant accomplishments include reductions in HIV-associated morbidity and mortality, introduction of less complex medications and dosing regimens, more thorough understandings of the processes surrounding HIV infection, and development of stronger social program infrastructures. As efforts to combat HIV and AIDS continue, serious shortfalls and knowledge gaps continue to elude clinicians and researchers alike. An HIV vaccine continues to evade scientific progress with few tangible products on the horizon. Drug resistance continues to be the paramount shortfall to medical treatment and management of HIV. Resistance to standard therapy will eventually develop even among the most adherent of patients. Lastly, quality of life issues continue to plague those living with HIV. Medications are often associated with untoward adverse effects, large pill burdens, complex dosing regimens, and high cost. Clinicians, researchers, and patients alike continue to confront these issues while envisioning a point where eradication of HIV is possible.Target Audience
This activity is intended for all social and healthcare workers impacted by Kentucky Revised Statutes 214.610/615/620.Objectives
1. Describe basic epidemiology associated with HIV disease.2. List current treatment guidelines for HIV and AIDS.
3. Discuss HIV transmission and prevention techniques.
4. Explain behavioral and cultural impact of HIV and AIDS.
Accreditation
MedicineThe University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
The University of Kentucky College of Medicine designates this educational activity for a maximum of 2.00 AMA PRA Category 1 Credits. Each physician should claim only those hours of credit actually spent in the educational activity.
The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.
Pharmacy
The University of Kentucky College of Pharmacy is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This activity has been assigned ACPE # 022-000-07-141-H02-P and will award 2.40 contact hours (0.24 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers. Statements of credit will indicate hours and CEUs based on successful completion of a posttest (score 70% or higher) and will be issued upon completion of the activity. The college complies with the Criteria for Quality for continuing education programming.
